The Region of 150 Kb Telometic to HLA-C is Associated with Psoriasis in the Jewish Population
Overview
Authors
Affiliations
The HLA-Cw*0602 has been associated with psoriasis in different ethnic groups. But, it remains unclear whether HLA-C is the PSORS1 gene (the psoriasis gene in the MHC). Thus, several case-control studies have been performed in order to investigate whether HLA-C itself determines the susceptibility to the disease. We studied 59 Jewish patients with type I psoriasis and 79 matched controls. Polymorphic genes and markers from HLA-B (centromeric to HLA-C) to the corneodesmosin (CDSN) gene (telomeric to HLA-C) were genotyped in order to determine their contribution to the susceptibility to psoriasis. Neither HLA-Cw*0602 nor the allele CDSN*TTC were significantly associated with psoriasis with the size of the sample studied. The genes and markers telomeric to HLA-C such as the microsatellite C1_4_4 (OR = 2.6, 95% CI = 1.4-4.7, p(c) = 0.018) the octamer transcription factor (OTF)-3 gene (OR = 2.6, 95% CI = 1.6-4.3, p(c) = 0.0001) and the alpha-helix coiled-coil rod homologue (HCR) gene (OR = 2.5, 95% CI = 1.3-4.5, p(c) = 0.004), however, were associated with the disease. These results suggest that a major psoriasis susceptibility gene is likely to be located within a region of 150 kb telomeric to HLA-C and centromeric to the CDSN gene.
Pham N, Nguyen T, Nguyen H Dermatol Reports. 2024; 16(2):9854.
PMID: 38957641 PMC: 11216135. DOI: 10.4081/dr.2023.9854.
Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients.
Ho S, Tsai T Mol Diagn Ther. 2022; 26(5):541-549.
PMID: 35789988 DOI: 10.1007/s40291-022-00603-4.
Chandra A, Senapati S, Ghosh S, Chatterjee G, Chatterjee R J Hum Genet. 2016; 62(3):389-395.
PMID: 27829679 DOI: 10.1038/jhg.2016.139.
Samandary S, Kridane-Miledi H, Sandoval J, Choudhury Z, Langa-Vives F, Spencer D Hum Immunol. 2014; 75(8):715-29.
PMID: 24798939 PMC: 4119854. DOI: 10.1016/j.humimm.2014.04.016.
Queiro R, Tejon P, Coto P, Alonso S, Alperi M, Sarasqueta C Clin Dev Immunol. 2013; 2013:482691.
PMID: 23690822 PMC: 3652135. DOI: 10.1155/2013/482691.